Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Posted in Uncategorized | 3 Comments

3 Responses

1. on September 17, 2015 at 2:35 AM | Reply creativebiolabs

   I was wondering whether there are more reliable evidences about the cancer survival.

   
   
2. on September 17, 2015 at 10:39 AM | Reply lbretes

   I think that this amazing, and medical oncologists must know about this new utility of old drugs(cheaper that MABs).Sometimes the clinitian prescribes this drug in another setting in these patiens(cardiovascular) and benefit the cancer patient……………..

   
   
3. on September 17, 2015 at 11:17 AM | Reply sjwilliamspa

   I will later in the week provide a curation of the history of the rationale for this study. It starts with microarray experiments done in the late 90’s.

   
   

Leave a Reply to creativebiolabs Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out /  Change )

You are commenting using your Google account. ( Log Out /  Change )

You are commenting using your Twitter account. ( Log Out /  Change )

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

Notify me of new comments via email.

Notify me of new posts via email.